Angiotensin-Derived Nootropic · Educational Resource

Understanding Dihexa and Synaptogenesis Research

Dihexa Synaptogenesis Research Philippines

Angiotensin IV Analog

(Small Molecule Compound)

Investigational Application

Synaptogenesis, cognitive research

Administration Protocol

Oral, per study protocol

Want to learn more?

A licensed team will reach out to guide you through the research.

Book a consultation →

Angiotensin-Derived Nootropic · Educational Resource

Understanding Dihexa and Synaptogenesis Research

01 — Overview

What is Dihexa?

Dihexa is a small molecule compound derived from angiotensin IV, originally researched in the context of Alzheimer's disease and cognitive decline studies.

As a very early-stage investigational compound, Dihexa has not received regulatory approval for therapeutic use in the Philippines or elsewhere, and existing literature is largely limited to preclinical, animal-model research.

Within research literature, Dihexa is most frequently studied for its relationship to synaptogenesis (the formation of new synapses) and memory-related pathways, areas summarized further below.

02 — How it works

How It Works: HGF/c-Met Pathway Activation and Synaptogenesis

As an angiotensin IV analog, Dihexa is studied for its ability to activate the hepatocyte growth factor (HGF) and c-Met receptor pathway, a signaling system researchers associate with synaptic growth and neural connectivity.

Literature describes this synaptogenic mechanism as significantly more potent in preclinical models compared to earlier compounds studied in the same research lineage, such as BDNF-based approaches.

Administration in Research

In preclinical literature, Dihexa is evaluated primarily via oral administration within controlled research protocols. As a very early-stage investigational compound, it has not received regulatory approval for therapeutic use, and research contexts differ from any at-home or self-directed use.

03 — Areas of research

Summary of Investigated Research Areas

Preclinical literature evaluates Dihexa across several key physiological parameters to map its biological interactions:

HGF/c-Met Signaling Pathways

Research literature evaluates how Dihexa is studied for its relationship to hepatocyte growth factor (HGF) and its c-Met receptor, pathways associated with synaptic growth.

Synaptogenesis Studies

Preclinical studies observe new synapse formation markers following Dihexa exposure in animal research models.

Memory Formation Parameters

Investigational literature examines spatial memory and learning parameters in preclinical research models.

Neurodegeneration Research

Studies explore Dihexa's studied relationship to neurodegenerative disease models, an area of its original research origin.

Blood-Brain Barrier Penetration Studies

Some literature investigates Dihexa's studied ability to cross the blood-brain barrier, a property relevant to its research applications.

Pharmacokinetic Profiling

Studies characterize the oral bioavailability profile of Dihexa in preclinical research.

04 — FAQ

Frequently Asked Questions

05 — References

References and Academic Literature

McCoy, A.T., et al. (2013). Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents. Journal of Pharmacology and Experimental Therapeutics.

Benoist, C.C., et al. (2011). The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System. Journal of Pharmacology and Experimental Therapeutics.

Wright, J.W., & Harding, J.W. (2015). The Brain Renin-Angiotensin System and Cognitive Function. Cellular and Molecular Neurobiology.

i

Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.

Getting started

How to Get Started?

Patient having a telehealth video consultation with a licensed doctor from home

1. Consult

Book a free consultation with our licensed healthcare team.

100 % online. Hassle-free. Convenient.

Friendly Philippine-licensed doctor standing and smiling, ready for your assessment

2. Real Human Assessment

Talk with Philippine-licensed doctors and get prescribed.

Always doctor-led—never just an online form.

Free consultation with licensed providers

Hand holding a Seenergie peptide program box, ready for doorstep delivery

3. Start your Program

Your medication is prepared and delivered to your doorstep.

No lock-ins. No hidden fees. No subscriptions.

Formulated in FDA-regulated pharmacies

Seenergie patient care agent wearing a headset, ready to assist on a call

4. Consistent care

Stay on track with regular weekly follow-ups. On your chosen communication platform.

Unlimited complementary follow-ups